Those patient-derived cancer models have been reported to partly recapitulate human cancers based on cellular heterogeneity (PDC, PDX, and PDCO), drug response (PDC, PDX, and PDCO), and tissue structure (PDX and PDCO) of human cancer [13,14,15]. This evidence concerns the gene PDC and cancer.